Project Grant HT94252310994
Award Date
9/1/23
Completion Date
8/31/25
Dollars Obligated
$370K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Australia
Similar Awards
This $1,072,784 federal Project Grant was awarded on May 1, 2024 by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to the University of Melbourne (Australia) to conduct research aimed at "IMPROVING OVARIAN CANCER OUTCOMES BY UNDERSTANDING AND TARGETING ACQUIRED RESISTANCE." The research project is scheduled for completion on April 30, 2028. The University of Melbourne has a history of successfully delivering...
The University of Melbourne was awarded a $768,263 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research on developing a novel inhibitor of ribosome biogenesis with antitumor activity in preclinical models of prostate cancer. The goal of the Military Medical Research and Development program is to transform military and public health through innovative medical research solutions. This award will...
This federal Project Grant award in the amount of $733,068.00 was issued by the Defense Health Agency to the University of Melbourne on September 1, 2023 under the Military Medical Research and Development program (CFDA 12.420). The funding will support a 3-year research project titled "Investigating Transcript Diversity as a Driver of Melanoma Progression and Recurrence." The University of Melbourne will conduct basic, translational, and clinical research aimed at developing new...
The Defense Health Agency awarded a $4,319,388 Project Grant to the University of Melbourne to fund research aimed at "TARGETING SENESCENT CELLS TO IMPROVE OUTCOMES FOR BREAST CANCER PATIENTS" over the period from September 1, 2024 to August 31, 2028. This grant is provided under the Military Medical Research and Development Program (CFDA 12.420), which supports biomedical research to improve the health and care of military service members, veterans, and their families. The...
The University of Melbourne was awarded an $854,195 project grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will support integrative molecular characterization and biomarker validation research in metastatic hormone-sensitive prostate cancer from September 2021 through August 2025. Through this funding, the University of Melbourne will conduct basic, applied, and advanced biomedical research to investigate medical...
The University of Melbourne was awarded a $591,778 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct research aimed at "Harnessing the Immune Response in Exceptionally Long-Term Survivors to Develop Novel Therapeutics." The project will run from May 1, 2024 to April 30, 2027. The University of Melbourne has a history of conducting federal research and consulting work in areas such as...
The University of Melbourne was awarded a $968,717 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research aimed at solving a major complication of Parkinson's disease - debilitating constipation. The research will utilize novel pharmacology to target this issue over a 3-year period from April 2025 to April 2028. The Project Grant supports the university's advanced biomedical research capabilities in medical...
The University of Melbourne received a $1,109,929 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop a neurotrophin therapy for clinical translation. The grant, awarded on September 1, 2024, will support research aimed at improving health outcomes for military service members, veterans, and the broader public by advancing innovative treatments for neurological disorders. The three-year project will...
The University of Melbourne was awarded a $2,394,446 project grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2025 to imagine imaging toxin-mediated alpha-synuclein in the eye. Through this award, the University of Melbourne will support the Military Medical Research and Development program's goals of transforming health care for service members and the...
The University of Queensland in Australia was awarded a $744,744 USD project grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project titled "Understanding the Role of Immature Myeloid Cells in Early Melanoma Establishment" from September 30, 2022 to September 29, 2025. Through this funding, researchers at The University of Queensland will investigate the role of immature myeloid...